AMGN · Healthcare
Amgen Inc
26/100
Smart-money confidence1 of 3 sources positive
Below average interest
No standout activity across the feeds we track.
What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
34
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$226.1B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NasdaqGS
About AMGEN INC
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients…
Who's behind the signal
Every informed buyer we can see on AMGN, across all three feeds.
Hedge funds · 7
D.E. Shaw & Co
Increased +625%
Citadel Advisors
Increased +281%
AQR Capital Management
Increased +97%
Bridgewater Associates (Dalio)
Increased +48%
Gotham Asset Mgmt (Greenblatt)
Unchanged
Millennium Management (Englander)
Decreased −66%
+1 more in the full breakdown below ↓
Congress · 21
David J. Taylor
sold
Sheldon Whitehouse
sold
Maria Elvira Salazar
sold
Alan Armstrong
sold
Marjorie Taylor Greene
bought
Lisa C. McClain
sold
Cliff Bentz
bought
Jefferson Shreve
sold
+13 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 50 on record
Disclosures from 2022-09-26 to 2026-08-26
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-08-26 | David J. Taylor · R-OH | House | Sold | $1,001 - $15,000 |
| 2026-08-12 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2026-06-05 | David J. Taylor · R-OH | House | Bought | $1,001 - $15,000 |
| 2026-04-17 | Maria Elvira Salazar · R-FL | House | Sold | $15,001 - $50,000 |
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Sold | $15,001 - $50,000 |
| 2026-03-24 | Maria Elvira Salazar · R-FL | House | Bought | $15,001 - $50,000 |
| 2026-02-26 | David J. Taylor · R-OH | House | Sold | $1,001 - $15,000 |
| 2026-01-29 | David J. Taylor · R-OH | House | Sold | $1,001 - $15,000 |
| 2026-01-16 | David J. Taylor · R-OH | House | Bought | $1,001 - $15,000 |
| 2025-12-03 | David J. Taylor · R-OH | House | Sold | $1,001 - $15,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-10-24 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-09-25 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-09-11 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-09-04 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2025-06-24 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-06-06 | Cliff Bentz · R-OR | House | Bought | $1,001 - $15,000 |
| 2025-05-14 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve · R-IN | House | Sold | $15,001 - $50,000 |
| 2025-05-05 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-04-16 | Jared Moskowitz · D-FL | House | Bought | $1,001 - $15,000 |
| 2025-04-15 | Tommy Tuberville · R-AL | Senate | Sold | $15,001 - $50,000 |
| 2025-04-11 | Jefferson Shreve · R-IN | House | Bought | $15,001 - $50,000 |
| 2025-04-08 | Robert P. Bresnahan, Jr. · R-PA | House | Sold | $1,001 - $15,000 |
| 2025-02-24 | Jefferson Shreve · R-IN | House | Bought | $15,001 - $50,000 |
| 2025-02-11 | Daniel Meuser · R-PA | House | Sold | $1,001 - $15,000 |
| 2025-01-06 | Emily Randall · D-WA | House | Sold | $1,001 - $15,000 |
| 2024-12-06 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2024-11-19 | Julia Letlow · R-LA | House | Sold | $1,001 - $15,000 |
| 2024-10-23 | Julia Letlow · R-LA | House | Bought | $1,001 - $15,000 |
| 2024-08-07 | Scott Franklin · R-FL | House | Bought | $50,001 - $100,000 |
| 2024-08-07 | Scott Franklin · R-FL | House | Bought | $1,001 - $15,000 |
| 2024-08-02 | Scott Franklin · R-FL | House | Bought | $1,001 - $15,000 |
| 2024-07-02 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2024-01-23 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2024-01-02 | Michael C. Burgess · R-TX | House | Sold | $15,001 - $50,000 |
| 2023-10-24 | Greg Stanton · D-AZ | House | Sold | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton · D-AZ | House | Bought | $1,001 - $15,000 |
| 2023-07-14 | Jared Moskowitz · D-FL | House | Bought | $1,001 - $15,000 |
| 2023-05-01 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-04-28 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2023-04-12 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-04-05 | Michael C. Burgess · R-TX | House | Bought | $15,001 - $50,000 |
| 2023-03-27 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-03-06 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-02-22 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-01-27 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2022-12-09 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-10-19 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-10-12 | Kathy E. Manning · D-NC | House | Sold | $1,001 - $15,000 |
| 2022-09-26 | Earl Blumenauer · D-OR | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
AMGEN INC isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
4
Increasing
2
Decreasing
1
Unchanged
Price History
Loading price data...
A member of Congress bought
A member sold
Return:
High:
Low:
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.3%
Position change
+625%
0.3% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+281%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+97%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
+48%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
—
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−66%
0.0% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−4%
0.0% of Dodge & Cox's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to AMGEN INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell AMGEN INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime